Centenary Institute Medical Innovation Award 2019

Stage: People's Choice Voting

ABOUT THE AWARDS

The Centenary Institute is dedicated to supporting the medical research sector as a whole. The Centenary Institute Medical Innovation Awards promote innovation and creativity in the sector and are committed to encouraging a domestic culture of scientific excellence.

Recognising - Australia’s spirited young post-doctoral scientists who are taking risks and tackling the big questions of medical research.

Fostering - Australia’s most promising and inspiring young biomedical scientists.

Encouraging - Innovation and creativity – the essential ingredients in all human endeavour.

Promoting - A domestic culture of brilliance in medical research.

Dr Kate McArthur, winner of the 2018 In Memory of Neil Lawrence Prize.

“An award like this, particularly for early career researchers, is unbelievable. It can be very difficult to get funding this early in your career. Awards like this help us convince the ‘big guys’ our ideas have merit, and that people are excited and interested in them”.

View Dr McArthur's 2018 application video.

View the full Award website


WHAT THE 2019 FINALISTS WILL RECEIVE

In Memory of Neil Lawrence Prize sponsored by Commonwealth Private - 1st Prize

The winner of the In Memory of Neil Lawrence Prize will receive $30,000 to support their project and a perpetual Nick Mount hand blown glass trophy.

Bayer Innovation Award - 2nd Prize 

The runner-up will receive $15,000 to continue to develop their research.

Harvard Club of Australia Foundation Travel Prize

The recipient of this prize will be awarded $5,000 for the purpose of travelling to Harvard University, Boston, Massachusetts, USA.

A People's Choice Award will be voted on by the general public and research community and the successful applicant will be awarded a $2,000 prize.


2019 ADJUDICATORS

The Prize’s stellar line-up of adjudicators comprises of some of the most distinguished and prestigious scientists around the world including members of the Centenary Institute Scientific Advisory Board.

Professor Ashley Bush

Director of the Oxidation Biology Unit at the Florey Institute of Neuroscience and Mental Health, Victoria, AUS.

Professor Sir Marc Feldmann AC

Head, Kennedy Institute of Rheumatology, leads the Cytokine and Cellular Biology section, University of Oxford, UK.

Professor Ian Frazer AC

Translational Research Institute Ambassador and Chair of TRI Foundation Board, The University of Queensland Diamantina Institute, Queensland, AUS

Professor Michael Good AO

Institute of Glycomics, Griffith University, Gold Coast Campus, Queensland, AUS.

Professor Michael W Parker

Director, Bio21 Molecular Science and Biotechnology Institute (Bio21 Institute), Professor, Department of Biochemistry and Molecular Biology, University of Melbourne and Head of Structural Biology ACRF Drug Discovery Centre, St. Vincent’s Institute of Medical Research, Victoria, AUS.

Professor Jenny Stow

Head, Protein trafficking and Inflammation University of Queensland Institute for Molecular Bioscience (IMB), The University of Queensland, AUS.

Professor Mathew Vadas AO

Executive Director, Centenary Institute, New South Wales, AUS.

Professor Jane Visvader

The Victorian Breast Cancer Research Consortium Laboratory, Walter and Eliza Hall Institute of Medical Research, Victoria, AUS.


PAST WINNERS

The history of Award Winners

2018 Centenary Institute Medical Innovation Award

2017 Centenary Institute Medical Innovation Award

2016 Centenary Institute Medical Innovation Award

2015 Centenary Institute Medical Innovation Award



TESTIMONIALS

DIRECTOR OF WEHI, PROFESSOR DOUG HILTON, BSC MONASH BSC (HONS) PHD MELBOURNE FAA FTSE

The Centenary Institute Lawrence Creative Prize is a wonderful initiative to award early career medical researchers who are embarking on their independent program. At a time where they haven’t built up the track record to compete with established, senior researchers, recognizing their creativity and innovation with the Lawrence Creative Prize not only offers them financial support but also boosts their profile, giving them a competitive advantage when applying for research funding.

I urge Australians and sponsors alike to get behind the Lawrence Creative Prize. You will be supporting our young scientists who have the brilliance to think of new ideas and the courage to test them out, in their common quest to advance our knowledge of the diseases affecting today’s society.

EXECUTIVE DIRECTOR OF GARVAN INSTITUTE OF MEDICAL RESEARCH, JOHN MATTICK AO FAA FRCPA(HON)

I am writing to say how influential and important the Centenary Lawrence Creative prize has become for young investigators in Australian biomedical research. The Centenary Institute is to be congratulated for this initiative, which has brought it great credit and great publicity. It is quickly becoming the premier prize for emerging investigators across Australia and, most importantly, rewards and encourages the beautiful and essential intersection between creativity, logic and achievement in science. I very much hope it will continue, and thank you on behalf of the community.

NOBEL PRIZE-WINNING IMMUNOLOGIST, PROFESSOR ROLF ZINKERNAGEL:

Typically, it is early in their careers that scientists are at their most creative. It’s as PhD students and post-doctoral fellows that they generate the ideas that set the pattern of their studies to come. I should know. My collaboration with Peter Doherty that led to our joint Nobel Prize began as a post-doctoral fellow in Canberra. But because early career researchers have no track record, support from the established funding bodies is hard to come by. So, I’m heartened to see a Prize whose purpose is to encourage Australia’s best young biomedical researchers to express their creativity. And it just might encourage them to stay in Australia and build their careers here.


THANK YOU TO OUR GENEROUS SPONSORS AND SUPPORTERS

Sponsors

 Funding Available

$52,000

Host

Many of our senior researchers are specialist clinicians at Royal Prince Alfred Hospital and lecturers at the University of Sydney. Their direct, personal experience with patients inspires their work to improve and save lives. Our close ties with the University and Hospital mean our scientists are not isolated from the people who are affected by the major diseases we are working to overcome. ...